Matches in Nanopublications for { ?s ?p "[Overall, our findings establish PCBD1 as a coactivator of the HNF1B-mediated transcription necessary for fine tuning FXYD2 transcription in the DCT and suggest that patients with HPABH4D should be monitored for previously unrecognized late complications, such as hypomagnesemia and MODY diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 15 of
15
with 100 items per page.
- assertion description "[Overall, our findings establish PCBD1 as a coactivator of the HNF1B-mediated transcription necessary for fine tuning FXYD2 transcription in the DCT and suggest that patients with HPABH4D should be monitored for previously unrecognized late complications, such as hypomagnesemia and MODY diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Overall, our findings establish PCBD1 as a coactivator of the HNF1B-mediated transcription necessary for fine tuning FXYD2 transcription in the DCT and suggest that patients with HPABH4D should be monitored for previously unrecognized late complications, such as hypomagnesemia and MODY diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Overall, our findings establish PCBD1 as a coactivator of the HNF1B-mediated transcription necessary for fine tuning FXYD2 transcription in the DCT and suggest that patients with HPABH4D should be monitored for previously unrecognized late complications, such as hypomagnesemia and MODY diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP256338.RAUjx7Dgje1CC9Wz9iP3oAie_DxWLnck-MgGj_nrJGKa4130_assertion description "[Overall, our findings establish PCBD1 as a coactivator of the HNF1B-mediated transcription necessary for fine tuning FXYD2 transcription in the DCT and suggest that patients with HPABH4D should be monitored for previously unrecognized late complications, such as hypomagnesemia and MODY diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256338.RAUjx7Dgje1CC9Wz9iP3oAie_DxWLnck-MgGj_nrJGKa4130_provenance.
- assertion description "[Overall, our findings establish PCBD1 as a coactivator of the HNF1B-mediated transcription necessary for fine tuning FXYD2 transcription in the DCT and suggest that patients with HPABH4D should be monitored for previously unrecognized late complications, such as hypomagnesemia and MODY diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Overall, our findings establish PCBD1 as a coactivator of the HNF1B-mediated transcription necessary for fine tuning FXYD2 transcription in the DCT and suggest that patients with HPABH4D should be monitored for previously unrecognized late complications, such as hypomagnesemia and MODY diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP256333.RAnXl3yf_LbjvqjTupX04d6caqGJguMEzvUzWpwqkkpOU130_assertion description "[Overall, our findings establish PCBD1 as a coactivator of the HNF1B-mediated transcription necessary for fine tuning FXYD2 transcription in the DCT and suggest that patients with HPABH4D should be monitored for previously unrecognized late complications, such as hypomagnesemia and MODY diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256333.RAnXl3yf_LbjvqjTupX04d6caqGJguMEzvUzWpwqkkpOU130_provenance.
- NP611100.RApbjy6WUebckdl5dl8MBsoUCdKT3nG-B4YGX9QylczdY130_assertion description "[Overall, our findings establish PCBD1 as a coactivator of the HNF1B-mediated transcription necessary for fine tuning FXYD2 transcription in the DCT and suggest that patients with HPABH4D should be monitored for previously unrecognized late complications, such as hypomagnesemia and MODY diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP611100.RApbjy6WUebckdl5dl8MBsoUCdKT3nG-B4YGX9QylczdY130_provenance.
- NP1126009.RAkxCOVdBAWf3aXcSFZq3BPptJxYiFdFHuxRAG-3Zn96g130_assertion description "[Overall, our findings establish PCBD1 as a coactivator of the HNF1B-mediated transcription necessary for fine tuning FXYD2 transcription in the DCT and suggest that patients with HPABH4D should be monitored for previously unrecognized late complications, such as hypomagnesemia and MODY diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126009.RAkxCOVdBAWf3aXcSFZq3BPptJxYiFdFHuxRAG-3Zn96g130_provenance.
- NP1126012.RAqmj7_niGERh9b5PYghJLS_ZuJlpgrYzfkwlm-WDhdzY130_assertion description "[Overall, our findings establish PCBD1 as a coactivator of the HNF1B-mediated transcription necessary for fine tuning FXYD2 transcription in the DCT and suggest that patients with HPABH4D should be monitored for previously unrecognized late complications, such as hypomagnesemia and MODY diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126012.RAqmj7_niGERh9b5PYghJLS_ZuJlpgrYzfkwlm-WDhdzY130_provenance.
- NP256334.RA4Yv3bjCwDMfSTqUSe1FFDinANBri-wqn77EIa3NrAnQ130_assertion description "[Overall, our findings establish PCBD1 as a coactivator of the HNF1B-mediated transcription necessary for fine tuning FXYD2 transcription in the DCT and suggest that patients with HPABH4D should be monitored for previously unrecognized late complications, such as hypomagnesemia and MODY diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256334.RA4Yv3bjCwDMfSTqUSe1FFDinANBri-wqn77EIa3NrAnQ130_provenance.
- NP1126004.RAPHzF1cMVm5CtU9MyNvs4i9Nci6fLFlvDE2F1n_k1HT0130_assertion description "[Overall, our findings establish PCBD1 as a coactivator of the HNF1B-mediated transcription necessary for fine tuning FXYD2 transcription in the DCT and suggest that patients with HPABH4D should be monitored for previously unrecognized late complications, such as hypomagnesemia and MODY diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126004.RAPHzF1cMVm5CtU9MyNvs4i9Nci6fLFlvDE2F1n_k1HT0130_provenance.
- NP1126005.RALf2R84J8_ALG6A_a8ZyR6NI918bcJae5MZ4BJSMRiFY130_assertion description "[Overall, our findings establish PCBD1 as a coactivator of the HNF1B-mediated transcription necessary for fine tuning FXYD2 transcription in the DCT and suggest that patients with HPABH4D should be monitored for previously unrecognized late complications, such as hypomagnesemia and MODY diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126005.RALf2R84J8_ALG6A_a8ZyR6NI918bcJae5MZ4BJSMRiFY130_provenance.
- NP1126008.RAJSZ2chXOQku1Y4SUYKZMUScjgdUi85Lt8Jna99cQtA4130_assertion description "[Overall, our findings establish PCBD1 as a coactivator of the HNF1B-mediated transcription necessary for fine tuning FXYD2 transcription in the DCT and suggest that patients with HPABH4D should be monitored for previously unrecognized late complications, such as hypomagnesemia and MODY diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1126008.RAJSZ2chXOQku1Y4SUYKZMUScjgdUi85Lt8Jna99cQtA4130_provenance.
- NP725094.RA2lyD5DXtYdokqkuyYXo34gTcxOiZQ8TO-fA11jKtqaI130_assertion description "[Overall, our findings establish PCBD1 as a coactivator of the HNF1B-mediated transcription necessary for fine tuning FXYD2 transcription in the DCT and suggest that patients with HPABH4D should be monitored for previously unrecognized late complications, such as hypomagnesemia and MODY diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP725094.RA2lyD5DXtYdokqkuyYXo34gTcxOiZQ8TO-fA11jKtqaI130_provenance.